Whitepapers
>All
Finding the Right CDMO for Your Niche Drug Project
March 14th 2023Tailored manufacturing capabilities are critical in a CDMO. But, when you’re sprinting to market with a niche product, a partner who can also source your raw materials and de-risk your regulatory pathway is everything. With the right partner, every point along the development and manufacturing value chain journey becomes accelerated.
Five “Must Ask” Questions to Find the Right CDMO
March 14th 2023Partner Smart with End-to-End CDMO. What if you could rely on one partner to source APIs, formulate and develop drug products, and manufacture at clinical and commercial scale? Rather than too many links in your supply chain, an end-to-end CDMO reduces layers of administration, gaps in knowledge, time, cost, and risk.
Five Reasons to Outsource API Procurement (Mar 2023)
March 14th 2023Optimizing API Procurement. Supply chain woes existed long before the pandemic, and not many scientists want to spend time sourcing ingredients. There is a way to ensure you get the right active pharmaceutical ingredients, at the right cost, with the right plan to scale: partnering with an API procurement and supply chain specialist.
DyadPalladate™ pre-catalysts: Cross-coupling made simple
March 2nd 2023This technical brief will start by outlining the importance of cross-coupling catalysts in the industry. It will then weigh up the benefits of existing in situ and pre-formed catalysts. The remainder of the technical brief introduces Johnson Matthey’s DyadPalladateTM pre-catalysts as a cost-effective and greener alternative to traditional in situ systems.
Sustained Release Gel Formulation
March 2nd 2023A long-acting injectable improves the patient’s experience by only requiring a once weekly, or monthly injection as opposed to a daily dosing regimen. The gel depot formulation is simple to manufacture, and easy to tune to the desired release duration and dose.
The Flexible Approach to Modern Large & Small Molecule Manufacturing
February 23rd 2023We look at the importance of finding suppliers able to develop and customise Process Intermediates to meet the rapidly-changing expectations of modern finished drug manufacturers, and the economic & logistic benefits of outsourcing Buffer manufacturing, especially with the rise of cell & gene therapy products.
GMP Grade PMSF and Protease Inhibitors
February 23rd 2023In this whitepaper we explore the role of GMP-grade Phenylmethylsulfonyl fluoride and other protease inhibitors in biopharmaceutical manufacturing, and we outline how Actylis’ high-purity and refined PMSF helps finished drug manufacturers to meet increasingly rigorous regulatory requirements.
On-Hand Biopharmaceutical Ingredients
February 23rd 2023We provide a list of readily available high-quality biopharma ingredients used for in vitro diagnostics, vaccines, cell cultures and preservatives that we keep on hand to service our biopharma customers. All these raw materials have a very short lead time to suit your rapidly-changing manufacturing needs.
Current & Future Trends in Biopharmaceutical Raw Material Selection
February 23rd 2023Our in-house experts, along with Cecile Bellamy from Pfizer, deep dive into the factors that are influencing our industry today and look at what trends are likely to impact us in the future. We cover topics including regulatory compliance, manufacturer flexibility & supply chain risk and debate the supplier vs partner relationship and the importance of collaboration as we face a challenging future.
Alcami Grows Contract Manufacturing and Laboratory Business 20% With Waters Partnership
February 20th 2023Read a compelling, detailed Case Study about how an innovation partnership with Waters Corporation enhanced Alcami’s capacity, efficiency, and compliance-readiness for their pharmaceutical manufacturing and analytical services to differentiate their offerings and drive business growth.
New Technology Advances Biopharma Chromatography Productivity (Feb 2023)
February 16th 2023Biologics manufacturers have been successful boosting yields and increasing throughput in upstream mAbs production. Those increased volumes create a new challenge: scaling downstream process chromatography to be as productive. This Avantor white paper details how technologies such as a novel protein A chromatography resin and the use of additives can improve efficiencies in this complex process step. The white paper also explores the benefits of expanding single-use and continuous processing systems to further streamline downstream production and improve cost profiles.
Overcoming The Challenges of Pediatric Formulation
February 15th 2023Pediatric formulations have become increasingly important as the healthcare field recognizes the huge impact that strict patient adherence can have on a treatment’s efficacy. But to overcome the challenges of adherence in children, drug developers need to consider innovative new dosage forms that can deliver flexible and convenient medications for young patients.
